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Abstract
Loss of the conserved ‘‘cryptic’’ plasmid from C. trachomatis and C. muridarum is pleiotropic, resulting in reduced innate
inflammatory activation via TLR2, glycogen accumulation and infectivity. The more genetically distant C. caviae GPIC is a
natural pathogen of guinea pigs and induces upper genital tract pathology when inoculated intravaginally, modeling
human disease. To examine the contribution of pCpGP1 to C. caviae pathogenesis, a cured derivative of GPIC, strain CC13,
was derived and evaluated in vitro and in vivo. Transcriptional profiling of CC13 revealed only partial conservation of
previously identified plasmid-responsive chromosomal loci (PRCL) in C. caviae. However, 2-deoxyglucose (2DG) treatment of
GPIC and CC13 resulted in reduced transcription of all identified PRCL, including glgA, indicating the presence of a plasmid-
independent glucose response in this species. In contrast to plasmid-cured C. muridarum and C. trachomatis, plasmid-cured
C. caviae strain CC13 signaled via TLR2 in vitro and elicited cytokine production in vivo similar to wild-type C. caviae.
Furthermore, inflammatory pathology induced by infection of guinea pigs with CC13 was similar to that induced by GPIC,
although we observed more rapid resolution of CC13 infection in estrogen-treated guinea pigs. These data indicate that
either the plasmid is not involved in expression or regulation of virulence in C. caviae or that redundant effectors prevent
these phenotypic changes from being observed in C. caviae plasmid-cured strains.
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Introduction
Chlamydiaceae are gram-negative obligate intracellular patho-
gens that infect ocular, genital and respiratory tissues in both
humans and animals. The genomes of chlamydial species are
highly conserved, which likely reflects the specific requirements of
intracellular pathogens for survival and the limited opportunity for
genetic exchange with other bacterial pathogens within this
intracellular niche (reviewed by Stephens et al. [1]). This high
degree of genetic-relatedness extends to carriage of a 7.5 kb
‘‘cryptic’’ plasmid by Chlamydia trachomatis (human), C. muridarum
(mice), C. psittaci (birds), C. felis (cats), strains of C. pneumoniae that do
not infect humans and C. caviae (guinea pigs). Plasmid-deficient C.
trachomatis isolates are extremely rare, leading to speculation on the
importance of the plasmid for chlamydial pathogenesis [2].
We developed a protocol for the derivation of plasmid-deficient
chlamydiae and demonstrated its efficacy using C. muridarum [3].
The plasmid-cured derivative of C. muridarum Nigg, strain CM972,
displays distinctive phenotypic changes in vitro and in vivo when
compared with its parent. CM972 is less infectious in vitro [3] and
this is associated with significantly reduced chlamydial load in the
oviducts of intravaginally inoculated mice [4,5]. In addition,
CM972 lacks the ability to accumulate glycogen within the
inclusion, a property shared by naturally occurring plasmid-
deficient isolates [3,6]. CM972 also did not cause oviduct
pathology or signal via Toll-like receptor 2 (TLR2) [4], which is
important for the development of oviduct pathology in this model
[7]. Importantly, primary infection with CM972 prevented the
development of pathology upon secondary challenge with wild-
type Nigg. Recently, we demonstrated that these phenotypic
changes are conserved in plasmid-cured C. trachomatis and
identified a number of PRCL that, in addition to plasmid-encoded
gene products, are candidate effectors of these virulence properties
[8].
C. caviae is a natural pathogen of guinea pigs that causes
inclusion conjunctivitis and respiratory infection in newborns. The
guinea pig has been used to model sexual transmission of
chlamydial infection from males to females [9] and to study
genital tract infection and disease pathology in females [10,11,12].
Nevertheless, C. caviae is more distant genetically from C. trachomatis
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30747and C. muridarum and differs phenotypically from them in several
respects including intrinsic resistance to sulphonamides [13],
non-fusing inclusions [14] and an inability to accumulate
glycogen [15]. We sought to examine the role of the conserved
cryptic plasmid more broadly within the Chlamydiacae by
examining the in vitro and in vivo consequences of curing the
plasmid from C. caviae. We hypothesized that plasmid-deficient
C. caviae would not activate TLR2 and would fail to cause
oviduct disease in the guinea pig model. However, in contrast to
plasmid-cured C. muridarum and C. trachomatis,p l a s m i d - c u r e dC.
caviae strain CC13 signaled via TLR2 in vitro and elicited
cytokine production in vivo similar to wild-type C. caviae.
Furthermore, pathology induced by guinea pig genital tract
infection with this strain was not reduced although we observed
more rapid resolution of infection with CC13 in estrogen-treated
guinea pigs. These data indicate that the association of the
chlamydial plasmid with virulence is not universally conserved
among chlamydial species.
Methods
Animals
Female 20-week-old outbred Hartley strain (Hilltop Labs,
Scottdale, PA) guinea pigs were used for experiments. Guinea
pigs were given food and water ad libitum in an environmentally
controlled room with a cycle of 12 h of light and 12 h of darkness.
All animals were determined to be seronegative for anti- C. caviae
antibodies prior to infection. All animal experiments were pre-
approved by the Institutional Animal Care and Use Committee of
the University of Pittsburgh Medical Center under protocol #
0807981.
Strains, cell lines and culture conditions
C. caviae, guinea pig inclusion conjunctivitis (GPIC) strain, was
provided by Dr. Roger Rank and plaque-purified before use.
Chlamydiae were cultured in L929 fibroblasts. Cells were infected
at an approximate MOI of 0.5–1 before being centrifuged for 1
hour at 37uC. The cell culture medium was then removed and
replaced with 1 X Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% heat-inactivated FBS, gentamicin (20 mg
ml
21) and 0.1 mgm l
21 cycloheximide. Infected cells were
harvested into sucrose phosphate glutamate buffer at 40 hours
post infection, sonicated, and maintained at 280uC. Bacteria were
subsequently titrated by either the plaque assay [3] or as inclusion
forming units (IFU) [16] using a genus-specific fluorescently tagged
anti-chlamydial LPS monoclonal antibody (Biorad, Hercules, CA).
Evaluation of plaquing efficiency under different culture condi-
tions (e.g. with or without centrifugation) was achieved by the
titration of individual strains by plaque-forming assay, with
indicated modifications, in parallel with titration to estimate
IFU. The efficiency of plaquing (EOP) was calculated as PFU
ml
21 /IFU ml
21.
Quantitative PCR
Total RNA was isolated from chlamydia-infected L929 cells
24 hours post-infection (MOI,1) using an RNeasy RNA
isolation kit (Qiagen, Valencia, CA). For quantitative PCR
analysis, the RNA (2 mg) was pretreated with DNase I (Ambion)
and cDNA prepared using an iScript cDNA synthesis kit
(BioRad, Hercules, CA) according to the manufacturer’s
instructions. Primer pairs for amplification of 16S rRNA and
the genes identified in this study (Table 1) were selected using
Beacon Designer 2.13 (Premier Biosoft International, Palo Alto,
CA). Primers were purchased from Integrated DNA Technology
(Coralville, IA). Real time PCR reactions were carried out using
iQ Sybergreen supermix (BioRad) in a BioRad iCycler using a
two step reaction, 95uC for 10 seconds, 55uC for 1 minute for a
total of 40 cycles. Melt curve analysis showed that the
accumulation of SYBR green-bound DNA was gene specific
and not caused by formation of primer dimers. Transcripts from
the 16S rRNA gene of C. caviae served as an endogenous
reference and data were analyzed by the 2
2DDCT method [17]
using BioRad proprietary software. Each sample was assayed in
triplicate and each experiment was performed at least twice.
Statistical significance was determined by using Student’s t test.
A p value of ,0.05 was considered significant.
In vitro analysis of TLR signaling
The following cell lines were examined: HEK293 cells stably
expressing either TLR2 or TLR4/MD2 [18]. X-ray-irradiated
preparations of chlamydiae were also assayed using HEK-TLR2
cells transfected with an NF- kB reporter plasmid as previously
described [8]. In addition, in vitro infection was performed in
murine bone marrow-derived dendritic cells (BMDDCs) cultured
following the procedure of Inaba et al. [19]. The TLR2 agonist,
Pam3Cys-Ser-(Lys)4 (Axxora, San Diego, CA), the TLR4 agonist
LPS (Sigma, St. Louis, MO), and human rTNF-a (R&D Systems,
Minneapolis, MN) were used as positive control stimulants. Cells
were plated in 24-well tissue culture dishes at a density of ,10
5
cells/well. Infections were conducted by overlaying cells with a
multiplicity of infection of 1 or 3. Cells were incubated for 24 hrs
at 37uC, 5% CO2. Supernatants from the HEK cells were
harvested and assayed for IL-8 (DuoSet, R&D Systems). The
BMDDC supernatants were assayed for IL-1a, IL-1b, IL-2, IL-4,
IL-5, IL-6, IL-9, IL-10, IL-12p70, IL-13, IL-17, G-CSF, GM-
CSF, KC, MIP-1a, TNFa, IFNc, and MCP-1 via Multiplex bead
assay (Millipore Billerica, MA). IL-2, IL-4, IL-5, IFNc, IL-9, IL-
12p70, IL-13, MCP-1 and IL-17 were not detected above media
(data not shown). BMDDC data points represent the mean levels
of two independent experiments 6 SD.
Infection
Guinea pigs were inoculated intravaginally with 10
6 IFU of
either GPIC or CC13 suspended in 30 ml SPG intravaginally.
Estradiol administration has been demonstrated to potentiate
infection and pathology in the guinea pig model [20] so selected
experimental groups were dosed with 1 mg sesame oil-emulsified
b-estradiol-3-benzoate (10 mg/ml) (Sigma) daily where indicated,
beginning 7 days before infection and continuing until sacrifice.
Three separate experiments were conducted with groups of
estrogen-treated animals sacrificed on days 9 or 30 and groups
of untreated animals sacrificed on day 30. The kinetics of lower
genital tract infection was monitored via culture of cervical swabs
on L929 cells.
In vivo cytokines
Guinea pig genital tract secretions were collected via vaginal
sponges as described previously [21]. Sponges were stored at
270uC until they were eluted individually in 0.5 ml of Eagle
minimal essential medium and assayed via ELISA for IL-8
(Human IL-8 DuoSet, R&D Systems).
Serum antibody
IgG1, and IgG2a, and IgA antibody to C. caviae in serum was
measured by an ELISA as described previously [22] using gradient
purified GPIC elementary bodies as antigen and goat, anti-guinea
pig-Ig antibodies obtained from AbdSerotech (Oxford, UK).
Plasmid-Deficient C. caviae
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Guinea pigs were sacrificed at day 9 or day 30 post infection, and
the entire genital tract was removed en bloc, fixed in 10% buffered
formalin, and embedded in paraffin. Longitudinal sections (4 mm)
were stained with hematoxylin and eosin and evaluated by a
pathologist blinded to the experimental design. Each anatomic site
(exocervix, endocervix, uterine horn, and oviduct) was indepen-
dently assessed for the presence of acute inflammation (neutrophils),
chronic inflammation (lymphocytes/monocytes), plasma cells, and
erosion of the mucosa. Right and left uterine horns and right and
left oviducts were evaluated individually. A four-tiered semiquan-
titative scoring system was used to quantify the inflammation as
previously described [5]. Oviduct dilatation scores also include a
subjective assessment of flattening of the oviduct epithelial plicae
and destruction of the oviduct mucosa.
Statistics
StatisticalcomparisonsbetweenGPICand CC13-infectedguinea
pigs for levels of infection and cytokine production over the course
of infection were made using a two-factor (days and strain) RM
ANOVA. A post-hoc Tukey test was used as a multiple comparison
procedure. Kaplan-Meier survival analysis was used to compare the
durations of infection over time. The Fisher-exact test was used for
determination of significant differences in frequency of pathological
characteristics between groups. One-way ANOVA on ranks was
used to determine significant differences in the pathological data
between groups. Statistical tests were performed using SigmaStat
software with p,0.05 considered significant.
Results
Plasmid-deficient C.caviae CC13 displays normal
infectivity
L929 cells infected with C. caviae GPIC were treated with
novobiocin (62.5 mg/ml) and plated in a plaque assay as previously
described for curing of the plasmid from C. muridarum [3].
Individual plaques were selected at random and each isolate was
plaque-purified twice more in order to obtain clones. A total of 28
clones were screened by PCR using primers directed against pgp1,
a gene encoded by the resident plasmid. Three plasmid-deficient
clones were identified and one was selected for further analysis and
designated strain CC13. Amplification and sequencing of a
portion of the 16S rRNA gene from CC13 (Fig. 1A, Table 1)
confirmed its genetic lineage, and Southern hybridization using a
1.58 Kb probe that spans the open reading frames encoding
pGP4-6 of pCpGP1 confirmed the absence of the plasmid from
this strain (Fig. 1B). PCR amplicons representing each of the
plasmid-encoded open reading frames were detected in C. caviae
GPIC only (Fig. S1).
C.caviaeGPICplaqueswerevisibleafter4–5daysincubation,and
unlike plasmid-cured C. muridarum CM972 [23] or C. trachomatis
CTD153 [8], no reduction in plaque size was observed for CC13
(Fig. 1 C). Furthermore, plaquing efficiency (EOP) in the absence
of centrifugation was similar for GPIC (EOP=2.77x10
226
1.94x10
22) and CC13 (EOP=2.59x10
2262.45x10
22), which
contrasted with the reduced efficiency we previously observed for
plasmid-cured C. muridarum [23] and C. trachomatis [8].
Table 1. PCR primer sets used in this study.
Strain Locus
a Sense Primer Anti-sense Primer
C. caviae 16S rRNA GCTCCTGGAGTTTACAGTGAA AAGAACGACGTTGGCGATAA
GPIC CCA_00078 (mip) TCCATTGCTTCCTGTGATTC TTGCGTAACTGTCTTGCG
CCA_00259 GAGGATAGGAAGGCTTGGAAC CACAAACATGCAAGCTCTATCTTC
CCA_00416 TTAGTGCGTGCTGGAGGAAG ATTGGCGAGGCTACAGAACC
CCA_00417 CTGTTGACCCCATAGAACCAC GAGCCTAGAAACGACTCAGATG
CCA_00453 GTTCTCAATGTCCGCAATACC TCAGCAAACTATACACATACTTCC
CCA_00523-525 GGGTTGGGATAATGGTTGG AGTTGCTCTGATTAAGTATTGC
CCA_00821 (glgA) AAG ATGATACATTACGCTTCA GCG TTAGAAGCCCCATATGCCAATCA
CCA_00924 AACGGCGATCTCCTTATC AAACCATAATTCCCAATCTCC
pCpGP1 pGP1-D CAGGTCTTGCAGCGACAACA* ACGTTCACCGTTCACGCTTA*
pGP1-D AGAAGCGCTAATAGCCCTTG TAGACCTTCCCAGCCTTCAC
pGP2-D AACAGACGTTCACCGTTCAC GCTGTTCTTCCCATCATCAC
pGP3-D GCGAAAGTTCCAGCTAGTTG ATGAGGTTGAGCGGGTTATG
pGP4-D TGGTTGGCCACTTTATCTCC GCATGCCTGCTTAACAACTC
pGP4-D-pGP6-D TAGGTTTGTTCCCCGACTCT* GACTTGATCTGCCCTGTT*
GP4/6 intrageneic AACAGGGCAGATCAAGTC GTTTGAGAAGCCCTCAAG
pGP6-D CATTCCTTCGTCGGTTCTTG CCTAGACTTGGTGGAGTATC
pGP7-D TGTTGAGAAAGATTTCCCAGAACTAGA TTGTTCGACTATAGGAGAGTCGGG
pGP8-D AACAACCTCCACACCAACAG TAACTAACAGCGCAAGGAGC
aChromosomal loci are identified by their annotated designations, C. caviae GPIC GenBank accession AE015925. Plasmid ORFs of pGPGP1 are indicated according to
GenBank accession AE015926 [45].
*Plasmid primers used to detect presence of pCpGP1 by PCR or DNA hybridization only.
doi:10.1371/journal.pone.0030747.t001
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partially conserved in C. caviae
Comparison of the transcriptional profiles of plasmid-cured
strains of C. muridarum and C. trachomatis revealed a conserved
group of plasmid-responsive chromosomal loci (PRCL) whose
transcription was altered in the absence of the plasmid [8]. To
determine if similar transcriptional changes have occurred in the
plasmid cured CC13 we first confirmed that the absence of the
plasmid does not impact the growth rate of CC13 when compared
to GPIC (Fig. 2A). Furthermore, RT-PCR confirmed that
transcripts of all plasmid-encoded ORFs could be detected by
24 hours after infection (Fig. 2B). Interestingly, both strains
resembled C. muridarum Nigg [4] in developmental profile because
new GPIC and CC13 EBs were detected in tissue culture by
16 hours post infection. Real time RT-PCR analysis of PRCL
homologs expressed by C. caviae revealed significantly decreased
transcription of several, but not all, of these genes at 24 hours post
infection, including the putative operon encoding CCA00523-525
and CCA00259 (Fig. 2C). Transcription of CCA00416 and
CCA00417, that encode orthologs of Pls1 and Pls2 [24]
respectively appeared only mildly reduced 24 hours after infection
(Fig. 2C). In contrast, transcription of CCA00453, encoding a
phospholipase D enzyme [25] and CCA00924 was not signifi-
cantly altered in CC13 (Fig. 2C) although all four of these genes
were plasmid-responsive in C. muridarum and C. trachomatis [8].
Transcription of glgA, the gene encoding glycogen synthase, is
plasmid-dependent in C. trachomatis [26] but not in C. muridarum
[8]. Transcription of glgA by CC13 was mildly increased whether
detected by microarray (data not shown) or by quantitative PCR
(Fig. 2C). A microarray screen comparing the transcriptional
profile of GPIC with CC13, 30 hours after infection confirmed
these findings (Fig. S2) and failed to detect additional plasmid-
responsive loci with orthologs in C. trachomatis and C. muridarum.
Transcription of C. trachomatis PRCL was coordinately reduced
in response to glucose limitation [8]. We examined the impact of
2DG treatment on the development of GPIC inclusions. L929 cells
infected with GPIC were cultured with medium containing the
glucose-6-phosphate inhibitor 2-deoxyglucose (2DG). Inclusions
formed by GPIC in the presence of 10mM 2DG appeared smaller,
with fewer EBs (Fig. 3B) when compared with those formed in
untreated cells (Fig 3A). Occasionally inclusions containing larger
aberrant forms were observed (Fig. 3C) that were not noted in the
untreated cells. Overall, the number of inclusions was reduced and
the infectious yield dropped ,100 fold after treatment (data not
shown). Treatment of GPIC-infected cells with 2DG also resulted
in significantly reduced transcription of glgA (,6 fold reduction)
and other PRCL homologs (4.5–34.4 fold reduction) (Fig. 3D).
Transcription of CCA00416, CCA00417, CCA00453 and
CCA00924 was also significantly reduced in CC13 in response
to treatment with 2DG (Fig. 3E) indicating that glucose-
responsiveness by C. caviae was not dependent on the presence of
the plasmid. These observations suggested a reduced role for
Figure 1. C. caviae CC13 is plasmid-deficient but displays no alteration in plaque size or efficiency. (A) Equal amounts of template were
added to PCR reactions with primers directed against the pgp1 coding sequence expressed by pCpGP1 or the C. caviae genome and amplified
products were analyzed on 2% agarose gels. (B) Genomic DNA was isolated from GPIC or CC13, digested with SphI and separated on a 1% agarose
gel. The DNA was transferred to a nylon membrane and probed for the presence of pCpGP1 DNA using a ,1.6 Kb probe directed against a region
spanning pGP4-6. Plasmid pCpGP1 was isolated from GPIC and digested with Sph1 to yield a single, linear fragment of ,7.9 kb which was used as a
positive control for hybridization. (C) Plaques formed by CC13 do not differ from those formed by GPIC. C. caviae-infected L929 monolayers were
incubated for 5 days at 37 C, 5% CO2, then the media overlay was removed and the plaques visualized using crystal violet.
doi:10.1371/journal.pone.0030747.g001
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indicated that plasmid-deficient C. caviae may not express pheno-
types described for plasmid-deficient C. muridarum and C. trachomatis.
C. caviae CC13 activates TLR2 signaling in vitro
Plasmid-deficient C. muridarum and C. trachomatis do not signal via
TLR2, and induce production of significantly lower levels of
proinflammatory cytokines than wild-type strains [4]. We infected
HEK 293 cells stably expressing TLR2 (HEK-TLR2) or TLR4/
MD2 (HEK-TLR4) with C. caviae GPIC or CC13. HEK 293 cells
endogenously express TLR1, TLR6 and MyD88, but not TLR2 or
TLR4 [18], thus, specific signaling canbe determined by measuring
cytokine production in cells stably transfected with TLR2 [23]
because TLR-ligand interactions are highly conserved in nature
[18]. Analysis of supernatants after 24 hours incubation revealed
similar levels of IL-8 production by HEK-TLR2 cells in response to
Figure 2. Transcriptional profiling of CC13 via microarray screening and quantitative RT-PCR reveals partial conservation of PRCL
but a plasmid-independent glucose response in C. caviae. (A) CC13 replicates normally during synchronous infection of L929 cells. GPIC and
CC13 were inoculated at an MOI ,1 into L929 cells growing in 24 well dishes, then samples were harvested at intervals and titrated to determine IFU/
well. (B) pCpGP1 transcripts are detected 24 hours after infection. Total RNA isolated from L929 cells 24 hours after infection with GPIC was treated
with reverse transcriptase to generate cDNA and assayed via RT-PCR. Purified genomic GPIC DNA was used as positive control for the reactions while
RNA processed for cDNA without reverse transcriptase was used as the negative control. (C) Quantitative RT-PCR confirms partial conservation of
candidate PRCL in C. caviae. Total RNA was isolated from infected cells 24 hours after infection and PRCL transcripts were measured by quantitative
RT-PCR. CCA00078 (mip) was included as a non-plasmid responsive control because we did not detect a difference in its transcription by microarray
screen.
doi:10.1371/journal.pone.0030747.g002
Plasmid-Deficient C. caviae
PLoS ONE | www.plosone.org 5 January 2012 | Volume 7 | Issue 1 | e30747infection with GPIC or CC13 (Fig. 4A). IL-8 production above
media was not detected in the supernatant of HEK-TLR4 cells
infected with either strain, consistent with the weak immunostimu-
latory capabilities of chlamydial LPS [27]. These data indicate that
despite absence of the plasmid, CC13 was able to induce TLR2-
dependent cytokine production at levels equivalent to GPIC.
Interestingly, while we observed no difference between TLR2
activation by CC13 or GPIC when we assayed X-ray inactivated
preparationsof the bacteria usingHEK-TLR2 cellstransfectedwith
an NF- kB reporter plasmid (Fig. 4B), we noted that the amount of
C. caviae required to activate TLR2 in these cells was considerably
lower (,100 fold reduced) when compared with C. muridarum Nigg
or its plasmid-cured derivative CM3.1, suggesting that the TLR2
ligands of this chlamydial species is extremely potent.
C. caviae is highly pro-inflammatory when compared
with C. muridarum in murine BMDDCs
C. muridarum plasmid-deficient strains induce significantly
less cytokine production by dendritic cells in vitro than their
wild-type parent [4]. We incubated murine bone marrow
derived dendritic cells (BMDDCs) with CC13, GPIC, C.
muridarum Nigg or CM3.1 to determine if dendritic cell cytokine
release was altered by the loss of the plasmid from C. caviae and
to compare cytokine release during infection with C. caviae or C.
muridarum. After 24 hours, BMDDCs stimulated with GPIC and
CC13 secreted IL-1a,I L - 1 b, IL-6, IL-10, G-CSF, TNF-a,G M -
CSF, MIP-1a, and KC. Strikingly, IL-6 (Fig. 4C), IL-1b
(Fig. 4D), IL-1a,I L - 1 0 ,M I P - 1 a, and KC (data not shown)
were secreted at significantly higher levels in response to
infection with C. caviae compared to C. muridarum,w h e r e a sG -
C S F( d a t an o ts h o w n ) ,G M - C S F( d a t an o ts h o w n ) ,a n dT N F - a
(Fig. 4E) levels were similar between the strains. In all instances,
we observed no difference in cytokine response to infection with
CC13 compared with GPIC. These data indicate that CC13
stimulated dendritic cell cytokine production to levels equivalent
to GPIC and contrasted with C. muridarum where wild-type Nigg
induced significantly greater cytokine release than plasmid-
deficient CM3.1.
Figure 3. Effect of 2DG treatment on inclusion formation and transcription by C. caviae. (A) GPIC inclusions in L929 cells 40 hours post
infection (A–C). Inclusions formed by GPIC in cells treated with 10 mM 2DG are smaller (B) and may contain aberrant forms (C). Cells were fixed with
methanol then stained with an anti-LPS monoclonal antibody and anti-mouse Alexa488 (secondary) to detect chlamydiae and cytoplasm was
counterstained with Evans Blue. All inclusions were imaged at 400x magnification. (D) GPIC differentially regulates candidate PRCL transcription in
response to 2DG treatment. Total RNA was isolated 24 hours after infection from infected cells treated with 10 mM 2DG and transcripts were
quantified as for Fig. 2D. (E) Reduced PRCL transcription is plasmid-independent in C. caviae. L929 cells infected with CC13 were treated with 2DG as
for ‘C’ and transcription of plasmid-insensitive loci 24 hours after infection was examined as before. The transcriptional differences are presented as
fold change in expression for each gene in a single representative experiment although each experiment was performed independently at least twice
and samples were assayed in triplicate. p values for transcripts indicated with * were ,0.05.
doi:10.1371/journal.pone.0030747.g003
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PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e30747Figure 4. CC13 signals via TLR2 and induces cytokine production at levels similar to wild-type GPIC. (A) IL-8 was measured in the
supernatants of HEK 293 cells transfected with control plasmid, TLR2 or TLR4 and infected with GPIC or CC13 for 24 hrs. At both an MOI of 1 and 3,
cytokine production did not differ between HEK-TLR2 cells infected with GPIC or CC13. Neither strain induced IL-8 levels above media for cells
transfected with control plasmid or TLR4. The pattern of IL-8 production after stimulation with LPS (TLR4 agonist), TNF (NF-kB agonist), or Pam3Cys
(TLR2 agonist) indicated that cytokine production was specific for the transfected TLR. (B) GPIC and CC13 express a potent, plasmid-independent
TLR2 stimulating activity. X-ray inactivated chlamydial suspensions at various MOIs were incubated with HEK-TLR2 cells transfected with an NF-kB
reporter plasmid. After 24 h of incubation NF-kB-induced secreted alkaline phosphatase activity was assayed using QUANTI-Blue. Bars represent the
mean 6 SE for three independent experiments. (C) Murine BMDDCs infected with GPIC or CC13 for 24 h did not differentially produce IL-6, (D) IL-1b,
or (E) TNF-a. Bars represent the mean 6 SD for duplicate wells. The data presented are from a single representative experiment that was performed at
least twice.
doi:10.1371/journal.pone.0030747.g004
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tract infection model
In order to determine the possible impact of plasmid-deficiency
on the virulence of C. caviae in the genital tract infection model,
groups of guinea pigs (N=5) were inoculated intravaginally with
either GPIC or CC13 and sacrificed on day 30. The course and
intensity of infection was monitored via endocervical swabs. No
difference in the magnitude or duration of infection was noted
between the strains (Fig. 5A). In addition, IL-8 levels measured in
genital secretions obtained during the first 10 days of infection
were similar in the two groups (Fig. 5B). Histologic examination of
oviduct tissue recovered from these guinea pigs failed to detect any
pathology regardless of infecting strain.
Treatment with estrogen maintains the reproductive tract
epithelium and results in dramatically increased bacterial burden
[28], which might facilitate detection of subtle differences in the
course of infection and outcome with respect to upper reproduc-
tive tract pathology between CC13 and its plasmid-containing
parent GPIC. Groups of estradiol-treated female guinea pigs
(N=5) were intravaginally inoculated with GPIC or CC13 and
sacrificed on day 9 or day 30 post-infection. Culture of
endocervical swabs again revealed no significant difference (two-
way RM ANOVA, p=0.898) in shedding of chlamydiae from the
lower genital tract between GPIC and CC13 infected animals
(Fig. 5C). However, GPIC infection was prolonged compared to
CC13 (Kaplan-Meier, p=0.02), with infection resolving by day 22
for CC13 and day 30 for GPIC (Fig. 5C). Swabs obtained from the
upper uterine horns of guinea pigs sacrificed on day 9 were titrated
via plaque assay and the bacterial burden did not differ
significantly (p=0.052, Student’s t-test) between the strains (GPIC:
9.8610
464.1610
4; CC13: 4.3610
362.1610
3 PFU/ml). Thus, in
estradiol-treated animals, the duration of genital tract infection
was shortened and upper genital tract bacterial burden was slightly
decreased during infection with CC13.
However, we were unable to detect differences in the cytokine
response to infection between estradiol-treated guinea pigs
infected with GPIC or CC13. Genital tract secretions collected
from CC13 and GPIC infected animals through day 10
contained similar levels of IL-8 (Fig. 5D). Examination of the
antibody response to infection in the estradiol-treated animals
Figure 5. Chlamydial burden and levels of IL-8 do not differ between GPIC and CC13 infected guinea pigs during genital tract
infection. Groups of 5 untreated (A, B) or estradiol-treated (C, D) female guinea pigs were intravaginally infected with either GPIC or CC13 and
sacrificed on day 30. (A) Monitoring of endocervical swabs during infection of untreated guinea pigs revealed that infectious bacteria were not
detectable after day 9 for either strain. (B) Vaginal sponges collected through day 10 revealed similar levels of IL-8 in GPIC and CC13-infected guinea
pigs. (C) The course of GPIC infection in estradiol-treated guinea pigs was prolonged compared to CC13. (D) IL-8 levels monitored during the first 10
days of infection were not different in estradiol-treated guinea pigs infected with GPIC and CC13. Bars represent the mean 6 SD of five guinea pigs
per group and each experiment was performed once.
doi:10.1371/journal.pone.0030747.g005
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day 30. Analysis of antibody titers revealed no difference in the
mean 6 SD log10 titers of IgG1 (GPIC, 3.9460.38 vs. CC13,
3.5160.35), IgG2a (GPIC, 3.8960.34 vs. CC13 3.5960.46) or
IgA (GPIC, 2.8160.3 vs. CC13, 2.8160.42) between the strains.
These data indicate that despite the mildly prolonged infection
observed during infection with GPIC, the humoral immune
response did not significantly differ from that of animals infected
with CC13.
Estradiol-treated guinea pigs exhibit similar inflammatory
scores and pathology during infection with GPIC or CC13
Genital tract tissues harvested from estradiol-treated guinea pigs
infected with GPIC or CC13 were analyzed histologically. The
groups sacrificed on day 9 post-infection were graded for cellular
infiltrates because infection was still present. The groups sacrificed
on day 30 were analyzed for cellular infiltrates and for pathology
remaining after clearance of infection. On day 9, the levels of
inflammation in the exocervix (data not shown), endocervix (data
Figure 6. Cellular infiltrates are similar early during infection in estradiol-treated guinea pigs infected with GPIC or CC13. Groups of
5 estradiol-treated female guinea pigs infected with GPIC or CC13 were sacrificed on day 9. Pathology scores for inflammatory cells in the (A) uterine
horns, and (B) oviducts were similar for GPIC- and CC13-infected animals. Boxes extend from the 25-75 percentiles and whiskers indicate the 5
th–95
th
percentiles. (C, E) Representative oviduct histologic sections at 40X and 200X magnification from a guinea pig infected with GPIC. (D, F)
Representative oviduct histologic sections at 40X and 200X magnification from a guinea pig infected with CC13. Data are from one experiment with 5
guinea pigs per group.
doi:10.1371/journal.pone.0030747.g006
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differ between the strains. On day 30, histologic examination did
not reveal any difference in the degree of inflammation in the
exocervix (Fig. 7A), endocervix (Fig. 7B), uterine horns (Fig. 7C) or
oviducts (Fig. 7D; Fig. 8 A–F) during infection with GPIC or
CC13. In addition, there was no difference in the percentage of
animals with oviduct dilatation (Fig. 8A) or degree of dilatation
between the groups (Fig. 8B–F).
The overall degree of oviduct dilatation and oviduct epithelial
cell damage resulting from genital tract infection was low. In
contrast, we observed severe abdominal pathology in 3 of 5 GPIC-
infected and 1 of 5 CC13-infected animals that were treated with
estradiol, with fibrous adhesions noted between the genital tract
and peritoneum, bowel, and bladder in these animals. These
findings had been previously described in estrogen-treated, GPIC-
infected guinea pigs by Rank et al [28] and are reminiscent of Fitz-
Hugh-Curtis syndrome observed in a subset of Chlamydia-infected
human females [29]. This syndrome results from migration of the
bacterium into the abdomen and leads to inflammation and
fibrous adhesions in infected women.
Discussion
Our studies [4,8] and others [26] have revealed an important
role for the chlamydial plasmid in the expression of key virulence
properties by both C. muridarum and C. trachomatis. However the
role of the resident plasmid in other Chlamydiaceae has not been
investigated. Strains of C. pneumoniae infecting humans generally
lack the plasmid, but it is present in strains that infect a diverse
range of other mammals including horses [30] and koalas [31].
Recent studies of C. felis clinical isolates indicate that plasmid
carriage is highly conserved [32] in this species suggesting that the
plasmid may be important for virulence, and although the plasmid
appears conserved in C. psittaci, plasmid-deficient strains have been
described [33]. In this study we investigated the role of the plasmid
in C. caviae, a natural pathogen of the guinea pig, by curing GPIC
of pCpGP1 to derive strain CC13 and by examining CC139s
ability to cause infection and genital tract disease.
Three plasmid-associated phenotypes have been identified in C.
muridarum and are conserved in C. trachomatis: plasmid-deficient
strains are unable to accumulate glycogen within the intracellular
inclusion during the developmental cycle, display reduced
infectivity in vitro [3], and in vivo [4] and do not stimulate
TLR2 signaling during infection [4]. Whether the effectors of
these phenotypes are encoded directly by the plasmid is unknown,
but we have identified a conserved group of plasmid-responsive
loci encoded on the chromosome that may also contribute to the
expression or regulation of these traits [8]. Microarray screening
using a custom GPIC array indicated that the transcriptional
profile of CC13 very closely resembled that of its parent, but we
nevertheless observed that several of the PRCL identified in
plasmid-deficient C. muridarum and C. trachomatis were also
differentially transcribed in CC13 including CCA00523-525
(orthologous to CT142-44 and TC_419-421), and CCA00259
(orthologous to CT382.1). However, other candidate PRCL such
as the CT084 (TC_0357) ortholog CCA00453, and the CT702
(TC_075) ortholog CCA00924 did not differ transcriptionally
from GPIC. Mild reduction in transcription of CCA00416-17
Figure 7. Cellular infiltrates are similar late during infection in estradiol-treated guinea pigs infected with GPIC or CC13. Groups of 5
estradiol-treated female guinea pigs were infected with GPIC or CC13 were sacrificed on day 30. Median pathology scores for inflammatory cells in
the (A) exocervix, (B) endocervix (B), (C) uterine horns, and (D) oviducts were similar for GPIC- and CC13-infected animals. Boxes extend from the 25–
75 percentiles and whiskers indicate the 5
th–95
th percentiles. Data are from one experiment with 5 guinea pigs per group.
doi:10.1371/journal.pone.0030747.g007
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did not reach significance. Furthermore, transcription of glgA
appeared slightly but significantly elevated (,2 fold) in C. caviae
CC13. The significance of this observation is unclear because
glycogen accumulation within wild-type C. caviae inclusions is not
observed and glycogen production by this chlamydial species has
not been detected [34] but indicates that glgA transcription is not
plasmid-dependent in C. caviae, more closely resembling what we
have previously observed for C. muridarum.
Phenotypic analysis of CC13 in vitro revealed that loss of
pCpGP1 did not impact plaque size or plaquing efficiency. GPIC,
in common with C. pneumoniae and C. psittaci, does not accumulate
glycogen intrainclusionally [15], so no change in iodine-staining
phenotype was anticipated and was not observed (data not shown).
Figure 8. Oviduct pathology is similar following infection with GPIC or CC13. Groups of 5 estradiol-treated female guinea pigs were
infected with GPIC or CC13 and sacrificed on day 30. (A) Bars represent the percentage of oviducts with a pathology score of $ 1 for degree of
infiltration of polymorphonuclear neutrophils (PMNs), lymphocyes/monocytes, plasma cells or oviduct dilatation. (B) Median pathology scores for
oviduct dilatation in GPIC- and CC13-infected guinea pigs. Boxes extend from the 25–75 percentiles and whiskers indicate the 5
th–95
th percentiles. (C)
Histologic sections of an oviduct from a representative estradiol-treated guinea pig on day 30 after infection with (C, E) GPIC or (D, F) CC13 shown at
100X and 200X, respectively. The oviduct architecture is intact with minimal inflammation and dilatation. Data are from the same experiment detailed
in Fig. 6.
doi:10.1371/journal.pone.0030747.g008
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expressed on stably transfected HEK293 epithelial cells, an
observation that contrasted with the plasmid-cured strains
CM972 and CTD153 that are unable to stimulate TLR2-
dependent signaling in vitro and in vivo [4,8]. The overall
conservation of chlamydial plasmid organization suggests that the
plasmid may not encode a pathogenic TLR2 ligand directly and
further, that the conservation of plasmid-responsiveness for
CCA00523-25 and CCA00259 indicates that their expression is
likely not required for TLR2 activation, reducing the likelihood
that their orthologs encode candidate TLR2 ligands in C.
trachomatis or C. muridarum. Alternatively, is also possible that
GPIC encodes additional TLR2 ligands that are unaffected by the
absence of the plasmid, preventing detection of differential TLR2
signaling effects as are observed in plasmid-cured C. trachomatis and
C. muridarum. In support of this hypothesis, we observed that GPIC
and CC13 activated TLR2 ,100 fold more effectively than C.
muridarum Nigg, reflecting the expression of a potent, plasmid-
independent TLR2 ligand by C. caviae.
CC13 and GPIC both displayed a strongly pro-inflammatory
profile in dendritic cells. Consistent with our observation that C.
caviae expresses a potent, plasmid-independent TLR2 ligand we
detected strong induction of both TNF-a and IL-6 by BMDDCs in
response to incubation with GPIC and CC13. C. caviae strongly
induced IL-1b production by BMDDCs while C. muridarum did
not. Prestimulation with TLR ligands is required for IL-1b
production during infection of macrophages with C. muridarum
[35]. The high levels produced by BMDDCs infected with GPIC
or CC13 suggests C. caviae is able to independently prime and
induce release of IL-1b in these cells, unlike C. muridarum. Thus, it
appears that in addition to a lack of plasmid-control for TLR2
activation, stimulatory pathways are activated by C. caviae
differentially when compared to C. muridarum.
In light of our discovery that TLR2 signaling and infectivity
were unimpaired in CC13 despite the absence of pCpGP1, it was
not surprising that we were unable to demonstrate any significant
attenuation in the guinea pig model of genital tract infection. Only
with the potentiating effects of estradiol treatment were we able to
detect a minor shortening in the course of infection and a slight
reduction in upper genital tract bacterial load. Ultimately, these
differences were not sufficient to drive differences in the
development of oviduct immunopathology. Intra-abdominal
adhesions were noted in animals in both groups and were likely
the result of prolonged inflammation caused by the enhanced
bacterial burden associated with administration of estradiol.
Comparisons of the effects of plasmid-curing on C. trachomatis, C.
muridarum and C. caviae gene expression, regulation and virulence
indicate significant differences that may be important for
understanding the outcome of genital tract infection with these
pathogens (Fig. 9). The overall similarity of both plasmid
organization and sequence homology is high. Recent phylogenetic
analysis of the plasmids expressed by 6 of the 9 chlamydial species
indicates that they group distinctly, in a manner greatly resembling
their genomes, with the plasmids obtained from C. pneumoniae
strains most closely related to each other and to a lesser extent to
those carried by C. psittaci, C. felis and C. caviae, and finally C.
muridarum and C. trachomatis isolates [31]. With such genetic
similarity, how can we account for the differences in phenotype
that we have observed in plasmid-cured strains? If the plasmid
encodes effectors of chlamydial virulence directly, why aren’t these
phenotypes conserved in all species that carry the plasmid?
Carlson et al. [26] proposed that the plasmid encodes a
transcriptional regulator, and we have identified a conserved
sub-population of chromosomal loci that are under its control [8].
However, we observed only partial conservation of plasmid-
dependence for these genes in C. caviae and if these are effectors of
these phenotypes in C. muridarum and C. trachomatis, then this is a
likely explanation of the failure of plasmid-curing to alter C. caviae
virulence.
Interestingly, we observed significant reduction of all candidate
PRCL transcription in GPIC in response to 2DG treatment,
indicating that C. caviae, like C. trachomatis, alters gene expression in
response to an environment in which glucose is limiting.
Furthermore, this response persisted in the cured CC13 strain
indicating that this process is plasmid independent. Consequently,
glgA expression was plasmid-insensitive but glucose-limited by C.
Figure 9. The impact of plasmid-curing on Chlamydia sp. gene expression, regulation and virulence. This diagram outlines the gene
expression and regulation and virulence phenotypes of plasmid-cured Chlamydia sp., and indicates the phylogenetic relationships of the plasmid
carried by these species or strains and other genera. Data regarding phenotypic and transcriptional responses were obtained in the course of this or
previous studies [3,4,5]. NT indicates where phenotype was not examined. The dendrogram was constructed via CLUSTAL [41] and Neighbor-joining
analysis was performed using plasmid sequences from C. trachomatis D/UW-3/Cx (pCTDLC1) [42], L2/434/Bu (pL2) [43], C. muridarum (pMoPn) [44], C.
caviae (pCpGP1) [45], C. psittaci pCpA1 (Lusher,M.E., Gregory,J., Storey,C.C. and Richmond,S.J., unpublished; Genebank: NC_002117, C. felis (pCfe1) [46]
and the non-human pathogens C. pneumoniae LPCoLN [31] and N16 (pCpnE1) [47] to determine branching order. The outcome of this analysis did
not differ from the more detailed analysis published by Mitchell et al. [31].
doi:10.1371/journal.pone.0030747.g009
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observations for both C. trachomatis where glgA transcription is both
plasmid and glucose sensitive and C. muridarum where glgA
transcription is unaltered in response to plasmid loss or glucose
limitation [8]. This may reflect a glucose-responsive regulatory
pathway evolving within Chlamydiaceae to facilitate modulation of
non-essential, plasmid-associated, virulence gene expression. This
is a common theme in bacterial pathogens where expression of
virulence loci may be tightly controlled in response to environ-
mental signals such as temperature [36], nutrient limitation [37],
carbon availability [38], or phosphate homeostasis [39]. In the
context of such a model, it appears that C. muridarum has not co-
evolved or has dispensed with the transcriptional controls exerted
by this pathway with the result that transcription of PRCL remains
constitutively active in glucose-limiting conditions [8]. If true, this
may explain the high incidence of upper reproductive tract
pathology observed in the mouse model [21] while human
infection is predominantly sub-clinical and reproductive tract
sequelae relatively uncommon [40]. Indeed, it may be worth
noting that neither C. caviae nor C. muridarum are natural pathogens
of the genital tract, infecting the eye and respiratory tract of their
respective hosts, so coordination of virulence-associated gene
expression in response to glucose availability might not be relevant
for these sites. Our preliminary observations indicate that TLR2
signaling by C. trachomatis but not by C. muridarum is impaired when
the chlamydiae have been cultured under glucose-restricted
conditions [8], but until the pathogenic TLR2 ligand(s) have been
identified, limited or altered expression of the TLR2 ligand(s)
cannot be confirmed. If correct, then identification and charac-
terization of the regulatory factor(s) encoded by the plasmid and
those involved in the chlamydial carbon response will greatly
advance our understanding of this important virulence process.
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